Welcome to Current Partnering – life science intelligence for deal makers

We are the publisher of CP Reports – life science deal term reports. We also produce Current Agreements – the leading comprehensive partnering, M&A, financing and company database.

In addition, we offer CP Insight – an interactive platform for an advanced level of deal making intelligence, and CP Knowledge Centre – our 3-in-1 life science intelligence package – ideal for users who need comprehensive access to all that Current Partnering has to offer.

New report

Provides comprehensive understanding and unprecedented access to the collaborative R&D partnering deals and agreements entered into by the worlds leading healthcare companies. More

 

Featured partnering deals

Banyan Biomarkers signs pharma licensing deal with Abbott

August 29, 2014 : Abbott, big pharma, biomarkers, partnering, pharma licensing

Banyan Biomarkers has licensed its intellectual property related to traumatic brain injury (TBI) biomarkers to Abbott for assessment and verification .

The terms of the in a pharma licensing agreement were not disclosed. more »

VIVUS pharma alliances with J&J for a group of patents

August 27, 2014 : big pharma, J&J, pharma alliances

VIVUS pharma alliances with Janssen Pharmaceuticals with the acquisition of a group of patents covering uses of topiramate as monotherapy and in combination with other pharmaceutical agents to treat a variety of medical conditions. more »

 More partnering deals | all deals at Deal Monitor


Featured M&A deals

Luye Pharma in m&a deal with Beijing Jialin Pharmaceutical for $599 m

September 1, 2014 : acquisition, merger

M&A news: Luye Pharma of China will pay $599 million to acquire a 58% stake in Beijing Jialin Pharmaceutical Co., a company that makes drug products for cardiovascular diseases and cancer. more »

Medtronic in yet another M&A deal worth $350 million

August 28, 2014 : CNS, m&a news

Medtronic has completed the acquisition of NGC Medical in a m&a transaction that values NGC at $350 million. more »

 More M&A deals | all deals at Deal Monitor

Featured financing deals

Dermira seeks $75 million in IPO financing

August 29, 2014 : dermatology, financing

Dermira plans to seek up to $75 million in an IPO financing. more »

Jaguar Animal Health headed towards $70m IPO financing

August 29, 2014 : animal health, financing

Financing news: The veteran of two biotech companies — Napo Pharmaceuticals Inc. and Shaman Pharmaceuticals Inc. — is leading a new company toward a planned $70 million initial public offering . more »

 More financing deals | all deals at Deal Monitor

Latest Dealtalk

Omega Pharma rumored to be sought after by big pharma companies

September 1, 2014 : acquisition, Bayer, big pharma, Boehringer Ingelheim, dealtalk, Sanofi

Belgium-based healthcare company Omega Pharma NV is allegedly attracting numerous bids from businesses across the big pharma companies, according to Bloomberg Businessweek. Perrigo and Boehringer Ingelheim GmbH are rumored to be interested in acquiring the company.  more »

AstraZeneca and Pfizer in the news for another possible m&a bid

September 1, 2014 : acquisition, AstraZeneca, dealtalk, Pfizer

AstraZeneca stock rose two percent to £45.67 pounds yesterday after the Swedish newspaper Dagens Industry suggested another possible Pfizer m&a  bid. AstraZeneca stocks have risen 9.5% in the last week, following a stream of good news regarding its pipeline and takeover bids by Pfizer. more »

 More dealtalk

Featured reports

Co-development Terms and Agreements

Publication date: August 2014

Personalized Medicine in Oncology Partnering Terms and Agreements

Publication date: August 2014

Licensing Terms and Agreements

Publication date: August 2014

Diagnostic Imaging Partnering Terms and Agreements

Publication date: August 2014

Trends in Therapeutic Partnering

Publication date: August 2014

Cancer Monoclonal Antibody Terms and Agreements

Publication date: August 2014

Monoclonal Antibody Terms and Agreements

Publication date: August 2014

Co-promotion & Co-marketing Partnering Terms and Agreements

Publication date: July 2014

Drug Delivery Terms and Agreements

Publication date: July 2014

Vaccine Partnering Terms and Agreements

Publication date: July 2014

Distribution Partnering Terms and Agreements

Publication date: July 2014

Diagnostics Partnering Terms and Agreements

Publication date: July 2014

Pharma and Biotech M&A Trends 2009-2014

Publication date: July 2014

Infectious Vaccines Partnering Terms and Agreements

Publication date: June 2014

Antibiotics Partnering Terms and Agreements

Publication date: June 2014

NEW: Therapy deal reports covering all major indications

Including partnering in oncology, cardiovascular, CNS, metabolic, dermatology, dental, infectives, immunologypsychiatry, genitourinary.....plus many others

View all reports

Scorecard

Current Partnering provides access to key deal metrics for all leading partnering, M&A and financings - plus big pharma partnering activity and R&D spend metrics.

Available scorecards:

Partnering

M&A

Financing

Top 50 pharma partnering

Top 50 biotech partnering

Top pharma R&D spend

Deal metrics - by stage of development, therapy area, industry sector

Print Friendly
cpbannerad300x150new2gif
RSS Feed Linked In Twitter

Latest Tweets

cpbannerad300x150new2gif
nlsd2014jpg
epicbanner1landscapejune11jpg